Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2012

Dec 5, 2012

30786_dirs_2012-12-05_943725db-c0ee-4975-ae56-3653f90c521f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2012-12-03

Reporting Person: SCHWARTZ ALICE N (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-03 Bio-Rad B Common Stock M 8000 $36.00 Acquired 489436 Direct
2012-12-03 Bio-Rad B Common Stock M 7608 $53.50 Acquired 497044 Direct
2012-12-03 Bio-Rad B Common Stock M 8227 $56.40 Acquired 505271 Direct
2012-12-03 Bio-Rad B Common Stock M 8413 $63.00 Acquired 513684 Direct
2012-12-03 Bio-Rad B Common Stock M 4000 $75.00 Acquired 517684 Direct
2012-12-03 Bio-Rad B Common Stock M 3000 $88.48 Acquired 520684 Direct
2012-12-03 Bio-Rad B Common Stock M 2000 $75.38 Acquired 522684 Direct
2012-12-03 Bio-Rad B Common Stock M 1000 $84.57 Acquired 523684 Direct
2012-12-03 Bio-Rad B Common Stock F 24014 $104.85 Disposed 499670 Direct
2012-12-03 Bio-Rad B Common Stock G 720 Disposed 498950 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-12-03 Non-Qualified Stock Option (right to buy) $36.00 M 8000 Disposed 2013-02-05 Bio-Rad B Common Stock (8000) Direct
2012-12-03 Non-Qualified Stock Option (right to buy) $53.50 M 7608 Disposed 2014-02-04 Bio-Rad B Common Stock (7608) Direct
2012-12-03 Non-Qualified Stock Option (right to buy) $56.40 M 8227 Disposed 2015-02-09 Bio-Rad B Common Stock (8227) Direct
2012-12-03 Non-Qualified Stock Option (right to buy) $63.00 M 8413 Disposed 2016-04-03 Bio-Rad B Common Stock (8413) Direct
2012-12-03 Non-Qualified Stock Option (right to buy) $75.00 M 4000 Disposed 2017-08-01 Bio-Rad B Common Stock (4000) Direct
2012-12-03 Non-Qualified Stock Option (right to buy) $88.48 M 3000 Disposed 2018-06-11 Bio-Rad B Common Stock (3000) Direct
2012-12-03 Non-Qualified Stock Option (right to buy) $75.38 M 2000 Disposed 2019-06-10 Bio-Rad B Common Stock (2000) Direct
2012-12-03 Non-Qualified Stock Option (right to buy) $84.57 M 1000 Disposed 2020-09-08 Bio-Rad B Common Stock (1000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 2772912 Direct
Bio-Rad A Common Stock 34311 Indirect
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 41176 Indirect

Footnotes

F1: The stock option exercise reported is the exercise of derivative securites acquired upon the death of the reporting person's spouse, David Schwartz, former Chairman of the Board of Bio-Rad Laboratories, Inc. and beneficial owner of more than 10% of the Company's Common Stock.

F2: 1,002 unvested restricted stock Class B shares held by the reporting person's late spouse, David Schwartz, were forfeited as of the date of his death, April 1, 2012.

F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner.

F4: The shares are held by a limited partnership of which the reporting person is a general partner.

F5: The stock option became exercisable in five equal annual installments beginning on February 5, 2004.

F6: The stock option became exercisable in five equal annual installments beginning on February 4, 2005.

F7: The stock option became exercisable in five equal annual installments beginning on February 9, 2006.

F8: The stock option became exercisable in five equal annual installments beginning on April 3, 2007

F9: The stock option became exercisable in five equal annual installments beginning on August 1, 2008.

F10: The stock option became exercisable in five equal annual installments beginning on June 11, 2009.

F11: The stock option became exercisable in five equal annual installments beginning on June 10, 2010.

F12: The stock option became exercisable in five equal annual installments beginning on September 8, 2011.